Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Neurosynaptic, the Leader in Telehealth Technologies, Announces a Strategic Investment from e-Zest
  • USA - English


News provided by

e-Zest Solutions Ltd.

Feb 07, 2014, 07:05 ET

Share this article

Share toX

Share this article

Share toX

Neurosynaptic the leader in Telehealth technologies announces a strategic investment from e-Zest
Neurosynaptic the leader in Telehealth technologies announces a strategic investment from e-Zest

Detroit, MI (PRWEB) February 07, 2014 -- Neurosynaptic’s industry-leading ReMeDi™ product remains the clear market leader focused on TeleHealth market in the developing countries it has always served. ReMeDi™ is now the largest Telehealth consulting technology platform in India with 1600 operational health centers. e-Zest’s strategic investment has positioned the Company to accelerate R&D and expansion of the product line allowing customers to derive more value from this mission critical solution.

We are really excited about being a partner in revolutionizing healthcare delivery using innovative technologies & business processes.

Post this

“In e-Zest, Neurosynaptic has found a partner that will help the company to grow at an accelerated pace while preserving our commitment to customers, partners and the markets that have been responsible for our success from the start,” said Sameer Sawarkar, Chief Executive Officer, Neurosynaptic Communications. “e-Zest’s extensive software product engineering & healthcare industry experience makes them an ideal partner as we realize our growth and expansion plans.”

Neurosynaptic’s Board will be joined by senior software industry entrepreneur & e-Zest’s President ShrikantShingane. Shrikant brings extensive experience with growing technology companies to Neurosynaptic and will focus on mentoring that will drive future growth of the company.

Unitus Capital was the sole advisor to Neurosynaptic for the transaction. “We are extremely thrilled to have partnered with Neurosynaptic in this critical transaction. We expect the strategic partnership between Neurosynaptic and e-Zest to be transformative for both companies and further revolutionize delivery of much needed healthcare services in India. Neurosynaptic is a leader in the Tele-Health domain and has done credulous work in India through their cutting edge technology solutions making healthcare both affordable and available in the excluded parts of the country; we are excited about the growth prospects for the sector and Neurosynaptic in the coming years.” stated Eric Savage, Co-Founder & President, Unitus Capital.

“We are really excited about being a partner in revolutionizing healthcare delivery using innovative technologies & business processes. By leveraging e-Zest’s expertise in Cloud, Mobile, UX & Analytics, our goal is to help ReMeDi™ become world leader in Tele-Health market” said Devendra Deshmukh, Chief Executive Officer, e-Zest.

“In addition to Devendra & Shrikant, we would like to thank Jaywant Deshpande, Co-founder, e-Zest for helping to realize this partnership as well as Gerald Manohar, Partner at JSA for acting as our legal counsel and Sunil Nanal, Partner at ‘Kanj and Associates’ for advising e-Zest on the transaction. We would also like to thank Technology Development Board, Department of Science and Technology for their continuing support for Neurosynaptic” said Rajeev Kumar, Director, Neurosynaptic.

About Neurosynaptics (http://www.neurosynaptic.com):
(Neurosynaptic) is a technology-led innovation company and is the leader in TeleHealth domain in India. Its flagship platform, ReMeDi™ has revolutionized remote healthcare space in India with its 1600 deployments reaching 45 Million population. ReMeDi™ has been deployed at several locations across the globe, impacting healthcare in several developing countries. Neurosynaptic has earlier been selected for the prestigious Technology Pioneer Award by the World Economic Forum, Switzerland; the Global Indus Technovator Award by IBC, MIT, Boston, was chosen as the fastest growing social enterprise in the health category by the ‘Action For India’ Forum, Delhi, India.

About e-Zest (http://www.e-zest.net) :
e-Zest is an ISO 9001:2008 and SEI CMMI Level 3 Global IT services company specialized in emerging technologies including cloud, mobility, analytics and UX. Being a customer focused and technology driven company it always help clients in crafting holistic business value for their IT initiatives. e-Zest is Microsoft Gold Certified partner and AWS Advanced Consulting Partner. It’s major offices are at Pune, Bangalore, Mumbai India and Detroit USA. It is consistently delivering cutting edge technology solutions to its broad range of clients from manufacturing, healthcare, technology, government/public sector and travel industries since its inception in 2000.

Devendra Deshmukh, e-Zest Solutions Ltd., http://www.e-zest.net, +91 9823310360, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.